Pseudomonas aeruginosa is an important opportunistic pathogen causing infections in patients suffering from cystic fibrosis, chronic obstructive pulmonary disease, or severe burns and in patients in intensive care units. It poses an overwhelming threat to these individuals, leading to a high risk of morbidity and mortality. The current treatment against P. aeruginosa usually includes a combination of ␤-lactam antibiotics and aminoglycosides (20) . However, resistance to these antibiotics is not uncommon, resulting in the failure of chemotherapy. P. aeruginosa also possesses various mechanisms to counteract antimicrobial agents. These include inducible AmpC ␤-lactamase (33) , plasmid-and transposon-encoded acquired ␤-lactamases (12) , multidrug efflux pumps (17) , low outer membrane permeability (53) , the ability to grow in biofilms (7) , and hypermutability (41) . The rapid emergence of resistance to ␤-lactam antibiotics in P. aeruginosa isolates from cystic fibrosis patients in the early 1990s has been attributed to the in vivo selection of constitutive ␤-lactamase-producing strains (6, 15, 16) . Overproduction of ␤-lactamase in some of the P. aeruginosa isolates has been ascribed to mutations in ampD encoding a negative regulator of AmpC (2, 28) , but genetic events underlying overproduction of AmpC ␤-lactamase still remain to be fully elucidated.
Many members of the Enterobacteriaceae family have genes that code for a chromosomal Ambler class C ␤-lactamase (38) . The analysis of chromosomally mediated ␤-lactamases revealed that, in species possessing an ampR gene, synthesis of ␤-lactamase is inducible, whereas in strains without ampR, synthesis is constitutive (44, 50) . The ampR genes in all the species studied thus far are located immediately upstream of ampC and are transcribed divergently (18) . The short intercistronic region of Citrobacter freundii ampR-ampC accommodates two overlapping promoters (3, 31) . The P. aeruginosa ampC and ampR genes have similar gene organization (32, 33) . However, the mechanism of ampR regulation in P. aeruginosa is not yet clear.
To address the role of P. aeruginosa ampR, we generated an ampR mutant in the prototypic, wild-type PAO1 strain. Our analysis of PAO1 and PAOampR showed that a mutation in ampR results in a high constitutive expression of ␤-lactamases and that AmpR is required for AmpC induction. In addition, AmpR modulates expression of yet another chromosomally encoded ␤-lactamase, extracellular proteases, and pyocyanin. Subsequent analyses suggest that AmpR affects the virulence factors through quorum sensing.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. Bacterial strains, plasmids, and primers used in this study are shown in Table 1 . Escherichia coli and P. aeruginosa 
a The italicized portion indicates a restriction site in a PCR product prepared with that primer.
were routinely cultured in Luria-Bertani medium (10 g tryptone, 5 g yeast extract, 5 g NaCl, per liter). Pseudomonas isolation agar (Difco) was used in triparental mating experiments. Antibiotics were used at the following concentrations (per milliliter) unless otherwise indicated: ampicillin at 50 g, tetracycline at 20 g, and gentamicin at 15 g for E. coli and carbenicillin at 300 g, gentamicin at 300 g, and tetracycline at 60 g for P. aeruginosa. For induction, 500 g/ml of benzylpenicillin was used. DNA manipulations. All molecular techniques were performed according to standard protocols (1) .
Cloning of ampC and poxB genes. Primers were designed to PCR amplify ampC and poxB. SBJ05ampCFor and SBJ06ampCRev were used to generate a 1,220-bp fragment with ampC, while KKF28poxBFor and KKF30poxBRev generated a 2,170-bp fragment containing poxB (Table 1 ). These PCR amplicons were electrophoresed and purified according to manufacturer's instructions (QIAGEN, California). The cleaned products were ligated into pCRII-TOPO and transformed into TOP10FЈ (Invitrogen, California). Because we were concerned that the presence of the bla gene in the pCRII-TOPO vector might interfere with data interpretation, an internal 712-bp DraI fragment of the bla gene was deleted, and the resulting vector was transformed into E. coli DH5␣. Selection was carried out using kanamycin, as this resistance marker was also present in pCRII-TOPO. The plasmids pSJ02 and pKKF675 harbored the ampC and poxB genes, respectively. The negative control, plasmid pKKF0679, contained a self-ligated pCRII-TOPO in which the bla gene was deleted (Table 1) .
Insertional inactivation of the ampR gene. A 1,220-bp ampR fragment was PCR amplified using SBJ01ampRFor and SBJ02ampRRev with flanking EcoRI and BamHI sites, respectively ( Table 1 ). The PCR product was ligated to an EcoRI-BamHI-digested pGEMEX-1 (Promega, California), generating pSJ01 ( Fig. 1) . A gentamicin cassette, aacCI, was retrieved from pUCGm (47) and inserted into the PstI site of ampR (Fig. 1) . This disrupted the reading frame of ampR in pSJ01. Subsequently, ampR::Gm was subcloned as an EcoRI-HindIIIcut, blunt-ended fragment into the SmaI site of pEX100T (48), which is a mobilizable suicide plasmid, creating pSJ07. This plasmid was conjugated into P. aeruginosa PAO1, with a helper strain harboring pRK2013 (11) . The merodiploids, resulting from homologous recombination, were selected with pseudomonas isolation agar containing gentamicin. Gm r colonies were then screened for gentamicin resistance and carbenicillin sensitivity by replica plating. The insertion was confirmed by PCR and restriction analysis on the PCR product (data not shown). The PAO1 isogenic strain with defective ampR, henceforth referred to as PAOampR, was named PKM300.
Construction of a plasmid with intact ampR for complementation. Plasmid pSJ06 was generated by subcloning an EcoRI-BamHI-cut fragment from pSJ01 containing ampR into an EcoRI-BamHI-cut, broad-host-range, low-copy-number plasmid, pME6030 (19) . This plasmid, pSJ06, also referred to as pAmpR, was used in all complementation analyses by conjugation into PAOampR.
Gene fusions with the lacZ gene. A 330-bp fragment was PCR amplified with the flanking primers SBJ03ampCRFor and SBJ04ampCRRev (Table 1) and then cloned into pGEMEX-1, generating pSJ09 (Fig. 1) . This fragment contained the ampC-ampR intergenic region with the putative promoters (33) . To avoid PCR artifacts, pSJ09 was sequenced by using M13 primers. The fragment containing the promoters was subcloned as an EcoRI-BamHI fragment into an EcoRIBamHI-cut, promoterless lacZ, mini-CTX-lacZ reporter plasmid (4), creating pSJ10 (P ampC -lacZ) and pSJ11 (P ampR -lacZ). This suicide vector contained the integration-proficient attP site, which recombines into the chromosomal attB site to generate a single-copy reporter fusion (4). The resulting clones were mobilized into PAO1 and PAOampR (Table 1 ). The presence of the chromosomal insertions was confirmed by PCR and restriction analysis of the product.
Pyocyanin quantitation assay. The pyocyanin assay is based upon the absorbance of excreted pyocyanin at 520 nm in acidic solution (9) . A 5-ml supernatant from a stationary-phase culture (ϳ16 h) in LB broth was mixed with 3 ml of chloroform. The pyocyanin from the chloroform phase was then extracted into 1 ml of 0.2 N HCl, giving it a pink to deep red color, indicating the presence of pyocyanin. The absorbance was measured at 520 nm. Concentrations, expressed (Table 1) . Plasmids pSJ01 and pSJ06 are derivatives of pGEMEX (Promega) and pME6030 (19) , respectively. The plasmid pSJ06 is used for complementation analysis and is referred to as pAmpR. The gentamicin cassette () was inserted into the SalI site of pSJ01, creating pSJ05. The ampR::aacCI (ampR::Gm) fragment was subcloned into the suicide vector pEX100T (48) to generate pSJ07, which was introduced into PAO1 to generate PAOampR by homologous recombination. A 342-bp fragment containing the promoters was cloned in both directions, upstream of promoterless lacZ (indicated by the striped arrows) in mini-CTX-lacZ (4) to generate the transcriptional fusions for ampC (pSJ10) and ampR (pSJ11) promoters. These fusions were introduced into PAO1 and PAOampR by site-specific recombination using the attP site (4).
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PSEUDOMONAS AERUGINOSA ampR 4569 as micrograms of pyocyanin produced per milliliter of culture supernatant, were determined by multiplying the optical density at 520 nm (OD 520 ) by 17.072 (9) . LasA staphylolytic assay. LasA protease activity was measured by determining the ability of stationary-phase P. aeruginosa culture supernatants to lyse boiled Staphylococcus aureus (25) . A 30-ml volume of an overnight S. aureus culture was boiled for 10 min and then centrifuged for 10 min at 10,000 ϫ g. The resulting pellet was resuspended in 10 mM Na 2 PO 4 (pH 4.5) to an OD 600 of approximately 0.8. A 100-l aliquot of bacterial supernatant was added to 900 l of S. aureus suspension, and the OD 600 was determined after 0, 5, 10, 15, 20, 30, 45, and 60 min (8, 25) .
LasB elastolytic assay. The elastolytic activity of bacterial suspension was determined with the elastin Congo red (ECR; Sigma, St. Louis, MO) assay (40) . A 100-l aliquot of bacterial supernatant of 16-h culture was added to 900 l of ECR buffer (100 mM Tris, 1 mM CaCl 2 , pH 7.5) containing 20 mg of ECR and then incubated with shaking at 37°C for 3 h. Insoluble ECR was removed by centrifugation, and the absorption of the supernatant was measured at 495 nm. LB medium was used as a negative control. Activity was expressed as change in OD 495 per g protein.
␤-Lactamase assay. The assay of the P. aeruginosa chromosomal ␤-lactamase was modified based on previously published protocols (39) . Briefly, stationaryphase cultures were diluted 1:100 into 10 ml of LB broth and incubated with shaking at 37°C until an OD 600 of 0.6 to 0.8 was attained. For induction (500 g/ml benzylpenicillin), the cultures were incubated for an additional 3 hours before harvesting. The cells were washed once with 50 mM sodium phosphate buffer and were then resuspended to a final volume of 2 ml of the same buffer. Following disruption of cells on ice with sonication, the cell lysate was centrifuged at 10,000 ϫ g for 30 min at 4°C and the supernatant was retained. A 2-l portion of the ␤-lactamase-containing supernatant was added to 1 ml (final volume) of assay buffer containing nitrocefin (final concentration, 100 M) at room temperature. The reaction was allowed to take place for 20 min before nitrocefin hydrolysis was measured spectrophotometrically at 482 nm. Concurrently, the total protein was determined with the Bradford assay using the same supernatant. One milliunit of ␤-lactamase is defined as 1 nanomole of nitrocefin hydrolyzed per minute per microgram of protein.
␤-Galactosidase assay. Assays for ␤-galactosidase in P. aeruginosa were performed as previously described (34) .
Statistical analysis. All data were analyzed with one-way analysis of variance using the statistical software package SPSS (Chicago, IL).
RESULTS AND DISCUSSION
Typically the presence of ␤-lactam antibiotics in a medium induces the synthesis of chromosome-encoded AmpC ␤-lactamase. The regulator of ampC, the divergently transcribed ampR gene product, has been identified in more than 10 species (18) . P. aeruginosa AmpR has a high sequence identity with the AmpR from C. freundii and Enterobacter cloacae (58.3 and 62.5% identity, respectively) (33) . Because the three species have the same ampR and ampC gene organization in the chromosome, it has been assumed that they also use the same regulatory mechanism. To date, the role of AmpR is restricted to the induction of ampC. The goal of this study was to examine the role of P. aeruginosa AmpR by generating an isogenic ampR mutant in the prototypic P. aeruginosa strain PAO1 (PAOampR).
P. aeruginosa AmpR does not autoregulate its own promoter. AmpR is a DNA-binding protein that belongs to the LysR family of regulatory proteins (22, 29, 31) . Many LysR-type transcriptional regulators act as transcriptional activators of the target genes but repress their own expression (45) . In addition, the P. aeruginosa ampR-ampC intergenic region is only 159 bp long, leading to the suggestion that the AmpR expression may be autoregulated (32) . To address this, we constructed strains with single copies of the ampR promoter upstream of a promoterless reporter gene, lacZ. The P ampRlacZ fusion was integrated into the PAO1 and the PAOampR chromosomes via attB-attP site-specific recombination, thus mimicking the chromosomal regulation (4). As a negative control, the promoterless lacZ gene was also integrated in both PAO1 and PAOampR. In the absence of the inducer, PAO1 showed a basal level of expression from the ampR promoter, which was not significantly affected by the presence of the inducer (Table 2 ). This finding concurs with previous C. freundii ampR studies showing that the amount of C. freundii AmpR expressed in E. coli minicells remains constant in the absence and presence of inducer (30) , that the constitutive ampR expression is low with a short half-life of mRNA (22) , and that the ampR transcription and the level of AmpR remain unaffected in the absence and presence of antibiotics (31) . Expression of P ampR -lacZ in the PAOampR mutant was not significantly different, suggesting that ampR does not regulate its own transcription ( Table 2) .
P. aeruginosa AmpR is a positive regulator of ampC expression. Class C ␤-lactamase has long been implicated as the culprit in the cephalosporin resistance of P. aeruginosa (5) . Based on previously published work in other systems (22, 30) , we postulated that the mutation in ampR would increase the activity of the ampC promoter. To test this hypothesis, we generated a P ampC -lacZ reporter and integrated it as a singlecopy fusion into the PAO1 and the PAOampR chromosomes via attB-attP site-specific recombination, thus mimicking the chromosomal regulation (4). As a negative control, the promoterless lacZ gene was also integrated in both PAO1 and PAOampR. In PAO1, little activity was synthesized from the ampC promoter (Table 2) . As expected, the presence of ben- zylpenicillin resulted in a significant elevation in the ampC promoter activity in PAO1 (Table 2) . However, no induction of the ampC promoter was detectable in PAOampR in the absence or presence of inducer. The significant loss of transcriptional induction of the ampC promoter (Table 2) was likely due to the absence of AmpR, suggesting that AmpR is a positive regulator of ampC expression in the presence of an inducer. This is in agreement with previous studies of C. freundii and E. cloacae demonstrating that AmpR modulates ampC expression. The cloned ampC genes from C. freundii and E. cloacae are activated in E. coli only if accompanied by their ampR gene (22, 30) . AmpR exhibits differential regulation on AmpC and PoxB. To ascertain the role of AmpR in the expression of ␤-lactamase, the activities in both PAO1 and the isogenic ampR mutant were compared. The parental PAO1 strain showed a low noninduced level of activity, which was increased 11-fold by addition of the ␤-lactam agent (Table 3) . However, PAOampR expressed a high ␤-lactamase level, 12-fold higher than that of the parental strain in the absence of inducer (Table 3) . No further induction was exhibited in the presence of a ␤-lactam agent. The inducible phenotype was restored in the PAOampR mutant by complementation with the plasmid pSJ06, harboring ampR.
However, based on the P ampC -lacZ expression assay (Table  2) , we expected the AmpC ␤-lactamase levels to remain the same in the absence of ampR (Table 3 ). This discrepancy in the biochemical and transcriptional analyses of ampC and the characterization of a P. aeruginosa ampC mutant led to the discovery of a novel chromosomally encoded class D ␤-lactamase, encoded by poxB (27) . This class D ␤-lactamase was independently reported by Girlich et al., and the enzyme was named OXA-50 (13) . However, our analysis of the sequence argues that PoxB is distinct from OXA enzymes (27) . This discovery led us to propose that AmpR might also regulate poxB. The presence of more than one copy of ␤-lactamases in P. aeruginosa complicated the analysis of the effects of AmpR on each of these genes in a homologous host model. Therefore, we cloned ampC and poxB genes into E. coli and analyzed their activity in the absence and presence of the ampR gene.
In strain E. coli DH5␣, AmpC expression was very low (Table 3 ). This is in contrast to what has been observed with C. freundii AmpC activity (30) . In the absence of ␤-lactam antibiotic and C. freundii ampR, an increase in C. freundii AmpC ␤-lactamase activity in E. coli was observed, suggesting that C. freundii AmpR is a negative regulator (30) . However, in our analysis, the presence of ampR is required for ampC expression.
Introduction of P. aeruginosa ampR into E. coli strain DH5␣ failed to induce the endogenous ␤-lactamase from the chromosomal ampC (Table 3) . However, when P. aeruginosa ampR was introduced along with its cognate ampC into E. coli strain DH5␣, the ␤-lactamase activity was significantly elevated both in the absence (fourfold) and in the presence (65-fold) of inducer (Table 3) , further supporting the notion that ampR is a positive regulator required for ampC expression as well as induction.
In contrast to ampC, the activity of poxB was constitutively high in E. coli (Table 3) . When AmpR was supplied in trans, poxB ␤-lactamase activity significantly dropped 65% and 96% in the absence and presence, respectively, of inducer (Table 3) . These data suggest that AmpR suppresses the expression of PoxB.
It has been demonstrated that the increased resistance in clinical isolates of P. aeruginosa is also due to the derepression of ␤-lactamase (5, 14) . Since the existence of PoxB was not known, and the biochemical assays used were not sensitive enough to distinguish these two ␤-lactamases, it was presumed that AmpC was overexpressed in the hyperproducing clinical isolates. A high constitutive expression of ␤-lactamase seen in PAOampR suggests that the clinical P. aeruginosa isolates that are hyperproducing ␤-lactamase may harbor poxB and a mutation in ampR. A Southern blot analysis of a few of these clinical P. aeruginosa isolates with ampR-and ampC-specific (27) . Mutation in ampR affects pyocyanin production. A change in virulence factor levels was first macroscopically observed when PAOampR produced a highly pigmented culture in midlog phase, compared to the parent PAO1. Pyocyanin is a typical green pigment produced by P. aeruginosa that is involved in microbial competitiveness, the suppression of soilborne plant pathogens, and virulence in human and animal hosts (35) . Two seven-gene phenazine biosynthetic operons, designated phzA1B1C1D1E1F1G1 and phzA2B2C2D2E2F2G2, are involved in pyocyanin production (35) . Besides the presence of a LasR binding site upstream of the phzA1 operon (35), little is known about the regulation of these operons.
In the parental strain PAO1, pyocyanin production was relatively low and inducible on antibiotic challenge, albeit insignificantly (Table 4) . However, pyocyanin production in the ampR mutant was significantly higher in the absence and presence of the ␤-lactam agent ( Table 4 ). The high constitutive pyocyanin level was reduced by ampR in trans from the lowcopy-number plasmid (Table 4 ). This suggests that AmpR negatively regulates pyocyanin production. It remains to be clarified if AmpR regulates one or both of these phz operons.
AmpR regulates staphylolytic protease LasA and LasB elastase. P. aeruginosa strains that overproduce pyocyanin are also known to produce other extracellular virulence factors. P. aeruginosa secretes a number of proteases, which are believed to play a major role in pathogenesis, especially during acute infections (26, 37) . We determined that the mutation in ampR also affects the expression of two proteases, the LasB elastase and the LasA staphylolytic protease.
LasA staphylolytic protease is a 20-kDa zinc metalloendopeptidase belonging to the ␤-lytic endopeptidase family of proteases (24) . The PAOampR supernatant lysed the Staphylococcus aureus cells at a significantly higher rate than PAO1 (Table 4) , indicating an increased production of LasA protease in the absence of ampR. This phenotype can also be rescued by ampR expressed in trans. This suggests that AmpR negatively regulates LasA protease production. Since AmpR is a homolog of LysR, the differential expression of LasA in PAOampR could be a result of the effect of AmpR on the transcription of lasA. To address this, we introduced plasmid pLPA containing P lasA -lacZ (43) into PAO1 and PAOampR (Table 5 ). In PAOampR, the P lasA expression was significantly increased compared to PAO1, suggesting that the increased transcription may contribute to a higher production of LasA staphylolytic protease. As expected, the induction was not influenced by the presence of inducer. It is interesting that the lasA promoter is significantly up-regulated in the presence of inducer.
Elastase, a zinc metalloprotease encoded by lasB, is capable 
